Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

At this year's Met Gala, India was represented by businesswoman Natasha Poonawalla. The executive director of vaccine production company Serum Institute of India wore a dress by designer Sabyasachi.
Describing her dress, Natasha, who is married to SII CEO Adar Poonawalla said that the 2022 Met Gala had a "prescient theme" in 'Gilded Glamour' which "resonates more strongly today than ever before".
Natasha added, "On the one hand, we see astronomical progress — to the degree that we’ve conquered space — and on the other hand we’re quick to police women or the vulnerable among us, their bodies, their choices, and their opportunities. It’s a bit like the golden cage."

Met Gala 2022: Indian vaccine firm Serum Institute of India's Natasha Poonawalla sole Indian at mega New York event

Met Gala: Serum Institute's Natasha Poonawalla sole Indian at mega New York event


THUMBNAIL INDIAN VACCINE FIRM'S EXEC DIR AT MET GALA
&nbsp;
&nbsp;
((VISUALS))
https://twitter.com/NPoonawalla/status/1521546105795788800
&nbsp; https://twitter.com/NPoonawalla/status/1521541357248163840
&nbsp;
At this year's Met Gala, India was represented by businesswoman Natasha Poonawalla. The executive director of vaccine production company Serum Institute of India wore a dress by designer Sabyasachi. Describing her dress, Natasha, who is married to SII CEO Adar Poonawalla said that the 2022 Met Gala had a "prescient theme" in 'Gilded Glamour' which "resonates more strongly today than ever before". Natasha added that on the one hand, we see astronomical progress &mdash; to the degree that we&rsquo;ve conquered space &mdash; and on the other hand we&rsquo;re quick to police women or the vulnerable among us, their bodies, their choices, and their opportunities. "It&rsquo;s a bit like the golden cage", she said.

Natasha Poonawalla, executive director of SII&nbsp;attended the Met Gala in New York

At this year's Met Gala, India was represented by businesswoman Natasha Poonawalla. The executive director of vaccine production company Serum Institute of India wore a dress by designer Sabyasachi.
Describing her dress, Natasha, who is married to SII CEO Adar Poonawalla said that the 2022 Met Gala had a "prescient theme" in 'Gilded Glamour' which "resonates more strongly today than ever before".
Natasha added, "On the one hand, we see astronomical progress &mdash; to the degree that we&rsquo;ve conquered space &mdash; and on the other hand we&rsquo;re quick to police women or the vulnerable among us, their bodies, their choices, and their opportunities. It&rsquo;s a bit like the golden cage."
Also Watch|&nbsp;<a href="https://www.editorji.com/entertainment-news/hollywood/met-gala-2022-blake-lively-sophie-turner-billie-eilish-and-others-stun-at-red-carpet-1651571237188" target="_blank">Met Gala 2022: Blake Lively, Sophie Turner, Billie Eilish and others stun at red carpet</a> &nbsp;

Even as the Serum Institute of India was being praised in the country for being one of the first vaccine-makers to start providing jabs against Covid-19, the company was facing criticism from foreign media. SII's CEO Adar Poonawalla made the revelation during a conversation with Sanjiv Goenka, chairman, RP-Sanjiv Goenka Group at All India Management Association's (AIMA) 7th National Leadership Conclave.
Poonawalla was asked by Goenka how he dealt with overnight stardom as the Covishield vaccine received approval to become one of the first vaccines to be administered in India. The SII CEO said that while Indian media was fair, foreign media criticised him as it didn't suit the West that "an Indian company had the quality and capability of contributing globally in such an important matter".
Poonawalla said that he received praise and criticism in equal measure at the time, and it was a difficult phase for him. The CEO said that he would be happy to "slowly" fade out of the limelight now.

Foreign media attacked Indian vaccine-maker SII for challenging Western firms' dominance, says Adar Poonawalla on Covid pandemic

Foreign media attacked Indian vaccine-maker SII for challenging Western dominance, says Adar Poonawalla

thumbnail
WHY WESTERN MEDIA ATTACKED S.I.I. FOR SUCCESS
&nbsp;
BYTE
SANJIV GOENKA, CONCLAVE CHAIRMAN &amp; CHAIRMAN, RP-SANJIV GOENKA GROUP https://www.youtube.com/watch?v=hlAxKgoP3hQ
(8:20 - 10:04)
 =========================================
CAPTIONS Serum Institute of India CEO's revelation Foreign media criticised SII: Poonawalla Indian firm's rise didn't suit them: SII CEO Happy to be out of limelight now: SII CEO

<div>Serum Institute of India's CEO Adar Poonawalla said that foreign media criticised India and his company amid Covid for challenging Western firms' dominance.</div>

Even as the Serum Institute of India was being praised in the country for being one of the first vaccine-makers to start providing jabs against Covid-19, the company was facing criticism from foreign media.&nbsp;SII's CEO Adar Poonawalla made the revelation during a conversation with Sanjiv Goenka, chairman, RP-Sanjiv Goenka Group at All India Management Association's (AIMA) 7th&nbsp;National Leadership Conclave.
<a href="https://www.editorji.com/partner/all-india-management-association/boosting-india-s-health-security-adar-poonawalla-in-conversation-with-sanjiv-goenka-1649847929961" target="_blank">Adar&nbsp;Poonawalla</a> was asked by Goenka how he dealt with overnight stardom as the Covishield vaccine received approval to become one of the first vaccines to be administered in India. The SII CEO said that while Indian media was fair, foreign media criticised him as it didn't suit the West that "an Indian company had the quality and capability of contributing globally in such an important matter".
ALSO WATCH:&nbsp;<a href="https://www.editorji.com/partner/all-india-management-association/boosting-india-s-health-security-adar-poonawalla-in-conversation-with-sanjiv-goenka-1649847929961" target="_blank">AIMA 2022: Serum Institute&rsquo;s Adar Poonawalla on building capacity and resilience</a>
Adar Poonawalla said that he received praise and criticism in equal measure at the time, and it was a difficult phase for him. The CEO said that he would be happy to "slowly" fade out of the limelight now.
Also Watch:&nbsp;<a href="https://www.editorji.com/partner/all-india-management-association/aima-conclave-2022-cea-v-anantha-nageswaran-talks-about-building-for-a-better-economy-1649924594182" target="_blank">AIMA 2022: CEA V Anantha Nageswaran talks about building for a better economy</a>

sii

Categories